Vickie McDonald

3.9k total citations
54 papers, 1.6k citations indexed

About

Vickie McDonald is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Vickie McDonald has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 19 papers in Genetics and 16 papers in Immunology. Recurrent topics in Vickie McDonald's work include Platelet Disorders and Treatments (35 papers), Blood groups and transfusion (15 papers) and Autoimmune Bullous Skin Diseases (13 papers). Vickie McDonald is often cited by papers focused on Platelet Disorders and Treatments (35 papers), Blood groups and transfusion (15 papers) and Autoimmune Bullous Skin Diseases (13 papers). Vickie McDonald collaborates with scholars based in United Kingdom, United States and France. Vickie McDonald's co-authors include Marie Scully, Samuel J. Machin, Beverley J. Hunt, Hannah Cohen, Jamie Cavenagh, Ian Longair, Adrian C. Newland, Siobhan McGuckin, John‐Paul Westwood and Maria Leandro and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Vickie McDonald

46 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vickie McDonald United Kingdom 15 1.1k 876 622 506 150 54 1.6k
Mari Thomas United Kingdom 15 687 0.6× 494 0.6× 366 0.6× 348 0.7× 87 0.6× 43 1.1k
V. Aumann Germany 9 1.3k 1.2× 902 1.0× 713 1.1× 400 0.8× 65 0.4× 30 1.7k
B. Brenner Israel 11 1.2k 1.1× 1.0k 1.2× 648 1.0× 381 0.8× 102 0.7× 21 1.7k
Manuela Krause Germany 14 1.2k 1.1× 1.0k 1.2× 670 1.1× 393 0.8× 133 0.9× 34 1.8k
A Lattuada Italy 20 551 0.5× 919 1.0× 216 0.3× 265 0.5× 280 1.9× 46 1.6k
Quentin A. Hill United Kingdom 21 353 0.3× 1.2k 1.4× 137 0.2× 439 0.9× 80 0.5× 60 1.8k
L Gugliotta Italy 21 363 0.3× 957 1.1× 137 0.2× 622 1.2× 59 0.4× 66 1.4k
Maddalena Marasà United States 14 263 0.2× 174 0.2× 826 1.3× 327 0.6× 266 1.8× 28 1.5k
Chi Hung To China 24 747 0.7× 184 0.2× 330 0.5× 78 0.2× 91 0.6× 45 2.0k
Satish Shanbhag United States 14 289 0.3× 337 0.4× 88 0.1× 190 0.4× 50 0.3× 37 931

Countries citing papers authored by Vickie McDonald

Since Specialization
Citations

This map shows the geographic impact of Vickie McDonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vickie McDonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vickie McDonald more than expected).

Fields of papers citing papers by Vickie McDonald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vickie McDonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vickie McDonald. The network helps show where Vickie McDonald may publish in the future.

Co-authorship network of co-authors of Vickie McDonald

This figure shows the co-authorship network connecting the top 25 collaborators of Vickie McDonald. A scholar is included among the top collaborators of Vickie McDonald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vickie McDonald. Vickie McDonald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, Nichola, A.J. Gerard Jansen, Robert Bird, et al.. (2025). Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study. American Journal of Hematology. 100(3). 439–449. 3 indexed citations
2.
Kuter, David J., Jiřı́ Mayer, Ross Baker, et al.. (2024). Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood Advances. 8(7). 1715–1724. 11 indexed citations
3.
4.
Fattizzo, Bruno, Andreas Glenthøj, Marc Michel, et al.. (2023). Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience. Blood. 141(16). 2016–2021. 8 indexed citations
5.
6.
Jansen, A.J. Gerard, Vickie McDonald, Adrian C. Newland, et al.. (2023). Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in The Netherlands (TRAPeze Netherlands study). Hematology. 28(1). 2267942–2267942. 7 indexed citations
7.
McDonald, Vickie. (2021). Acquired disorders of coagulation. Medicine. 49(4). 221–224.
8.
Platton, Sean, Andrew Bartlett, Peter MacCallum, et al.. (2021). Evaluation of laboratory assays for anti‐platelet factor 4 antibodies after ChAdOx1 nCOV‐19 vaccination. Journal of Thrombosis and Haemostasis. 19(8). 2007–2013. 90 indexed citations
9.
Januzzi, James L., Joseph Garasic, Scott E. Kasner, et al.. (2020). An independent review of arterial occlusive events (AOEs) in the ponatinib (PON) phase II PACE trial (NCT01207440) in patients (pts) with Ph+ leukemia.. Journal of Clinical Oncology. 38(15_suppl). 7550–7550. 5 indexed citations
10.
Kuter, David J., Ralph V. Boccia, Eun‐Ju Lee, et al.. (2019). Phase I/II, Open-Label, Adaptive Study of Oral Bruton Tyrosine Kinase Inhibitor PRN1008 in Patients with Relapsed/Refractory Primary or Secondary Immune Thrombocytopenia. Blood. 134(Supplement_1). 87–87. 10 indexed citations
11.
Saha, Prakash, Adam Gwozdz, Karen Breen, et al.. (2017). Stenting Across the Inguinal Ligament in Post Thrombotic Syndrome Using Nitinol Venous Stents: One-year Patency Outcomes. European Journal of Vascular and Endovascular Surgery. 54(5). 664–664. 1 indexed citations
12.
McDonald, Vickie, et al.. (2015). Is there benefit in extensive screening for cancer in patients with unprovoked venous thromboembolism?. Thrombosis Research. 136(6). 1332–1333. 1 indexed citations
13.
McDonald, Vickie & Steve Austin. (2013). Inherited bleeding disorders. Medicine. 41(4). 231–233.
14.
McGuckin, Siobhan, et al.. (2012). Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse. Journal of Thrombosis and Haemostasis. 11(3). 481–490. 125 indexed citations
15.
McDonald, Vickie, Ri Liesner, John D. Grainger, et al.. (2010). Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays. Blood Coagulation & Fibrinolysis. 21(3). 245–250. 17 indexed citations
16.
McDonald, Vickie, et al.. (2010). Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 8(6). 1201–1208. 85 indexed citations
17.
McDonald, Vickie & Maria Leandro. (2009). Rituximab in non‐haematological disorders of adults and its mode of action. British Journal of Haematology. 146(3). 233–246. 39 indexed citations
18.
McDonald, Vickie, Michael Laffan, Sylvia Benjamin, et al.. (2008). Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry. British Journal of Haematology. 144(3). 430–433. 34 indexed citations
19.
20.
Olson, Mary C., et al.. (1989). Computed tomography and magnetic resonance imaging of the pericardium.. Radiographics. 9(4). 633–649. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mari Thomas Breakdown of academic impact, for papers by V. Aumann Breakdown of academic impact, for papers by B. Brenner Breakdown of academic impact, for papers by Manuela Krause Breakdown of academic impact, for papers by A Lattuada Breakdown of academic impact, for papers by Quentin A. Hill Breakdown of academic impact, for papers by L Gugliotta Breakdown of academic impact, for papers by Maddalena Marasà Breakdown of academic impact, for papers by Chi Hung To Breakdown of academic impact, for papers by Satish Shanbhag
Rankless by CCL
2026